4025 Bohannon Dr.
3 articles with Deepcell, Inc.
BioSpace is proud to present its NextGen Bio “Class of 2022,” a list of up-and-coming life sciences companies in North America that recently launched.
As the capabilities have been proven, AI is establishing a firm foothold in the key areas of R&D, drug development, clinical trials, and, to some extent, patient-facing products.
Deepcell Closes $20 Million Series A Round to Develop AI-Powered Capture of Cells for Precision Medicine
Deepcell, a life science company pioneering AI-powered cell classification and isolation for cell biology and translational research, today announced that it has closed its Series A round of financing with $20 million, led by Bow Capital and joined by Andreessen Horowitz, which led its $5 million seed round